Icahn confederate could profit off a seat on Forest board

Carl Icahn accuses Forest Laboratories ($FRX) of bad governance. But is Icahn calling the kettle black? Experts are raising questions about his incentive plan for one nominee to Forest Labs' board. Icahn promised Eric Ende, a former biotech analyst and close associate, a cut of the profits if Forest's stock increases past $47.50 per share. As Reuters reports, Ende's 1% share of those profits would amount to $659,000, if Icahn were to sell his Forest stock at a $50-per-share price. Report